Nasal Decongestant (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride is a selective alpha‑adrenergic agonist. When sprayed into the nose it binds to alpha‑1 and alpha‑2 receptors on the nasal blood vessels, causing them to constrict. This vasoconstriction reduces mucosal edema and opens the nasal airway, providing rapid decongestion.

The appropriate dose and frequency are determined by the prescribing healthcare professional. Typically, one or two sprays per nostril every 10 to 12 hours are used, but the exact regimen should follow the prescriber’s instructions and the product label.

Safety in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk, and after consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Oxymetazoline is a potent alpha‑adrenergic agonist that provides rapid relief, often lasting up to 12 hours per dose. Compared with phenylephrine, oxymetazoline generally has a longer duration of action and may be more effective for severe congestion, but both share similar safety considerations regarding rebound congestion.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and extreme heat. Ensure the spray tip is clean and avoid contaminating the bottle.

The spray is applied intranasally. After gently shaking the bottle, insert the nozzle into one nostril, close the opposite nostril, and press the actuator to deliver the recommended number of sprays. Repeat in the other nostril if directed, and avoid blowing the nose immediately after use.

The most serious risks include rebound congestion (rhinitis medicamentosa) if used longer than three days, significant elevation of blood pressure, and rare severe allergic reactions such as anaphylaxis. Users should discontinue use and seek medical attention if these symptoms occur.

Individuals with known hypersensitivity to oxymetazoline or any formulation components, patients with severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors should avoid using this product unless advised otherwise by a healthcare professional.